Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E18.50 EPS (ttm)1.64 Insider Own0.10% Shs Outstand6.37B Perf Week-0.69%
Market Cap193.33B Forward P/E13.44 EPS next Y2.26 Insider Trans10.07% Shs Float6.37B Perf Month3.55%
Income11.03B PEG6.22 EPS next Q0.57 Inst Own80.40% Short Float1.03% Perf Quarter-0.33%
Sales50.53B P/S3.83 EPS this Y37.50% Inst Trans12.66% Short Ratio2.41 Perf Half Y-0.46%
Book/sh12.17 P/B2.49 EPS next Y0.85% ROA23.50% Target Price34.65 Perf Year7.09%
Cash/sh5.32 P/C5.71 EPS next 5Y2.98% ROE52.80% 52W Range27.08 - 32.67 Perf YTD0.76%
Dividend1.04 P/FCF18.72 EPS past 5Y6.80% ROI10.50% 52W High-7.12% Beta0.68
Dividend %3.43% Quick Ratio2.10 Sales past 5Y1.30% Gross Margin81.90% 52W Low12.06% ATR0.39
Employees77700 Current Ratio2.30 Sales Q/Q-8.50% Oper. Margin34.00% RSI (14)53.44 Volatility1.11% 1.34%
OptionableYes Debt/Eq0.48 EPS Q/Q-2.80% Profit Margin81.20% Rel Volume0.51 Prev Close30.39
ShortableYes LT Debt/Eq0.36 EarningsJul 29 BMO Payout16.40% Avg Volume27.21M Price30.34
Recom2.30 SMA200.36% SMA501.87% SMA200-0.15% Volume14,271,100 Change-0.16%
02-Jul-13Downgrade Standpoint Research Hold → Sell $24
15-Apr-13Reiterated Barclays Equal Weight $25 → $32
30-Jan-13Reiterated UBS Buy $29 → $31
30-Jan-13Reiterated Argus Buy $28 → $32
22-Jan-13Reiterated Barclays Equal Weight $24 → $25
27-Nov-12Downgrade MKM Partners Buy → Neutral $29 → $25
05-Oct-12Reiterated MKM Partners Buy $27 → $29
01-Nov-11Downgrade Standpoint Research Buy → Hold
07-Oct-11Initiated MKM Partners Buy $20.50
14-Sep-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
10-Aug-11Upgrade Argus Hold → Buy $21
05-Aug-11Upgrade Standpoint Research Hold → Buy $21
14-Mar-11Downgrade Standpoint Research Buy → Hold
03-Nov-10Downgrade Argus Buy → Hold
21-May-10Initiated Jefferies Buy $17.80
16-Dec-09Initiated UBS Buy
27-Apr-09Initiated Standpoint Research Buy $20
12-Feb-09Upgrade Leerink Swann Mkt Perform → Outperform
09-Feb-09Upgrade UBS Neutral → Buy
02-Feb-09Upgrade Credit Suisse Neutral → Outperform
24-Jul-14 04:40PM  Can GlaxoSmithKlines Slumping Stock Recover? at Wall St. Cheat Sheet
12:04PM  Botox Makers Bosses Put Money Where Their Mouths Are at New York Times
12:04PM  Allergans Bosses Put Money on Where Their Mouths Are at New York Times
11:21AM  Pfizer Needs to Do a Deal, Analyst Says at The Wall Street Journal
09:48AM  What Will Puma Biotechnology Inc's $700 Million Man Do Next? at Motley Fool
09:16AM  Did Pfizer Make A Horrible Business Deal? at Seeking Alpha
08:03AM  [video] Caterpillar CEO sees mining 'green shoots' at CNBC
07:09AM  [video] Eli Lilly looking for smaller acquisitions: CEO at CNBC
07:07AM  [video] Results hurt by patent expirations: Eli Lilly CEO at CNBC
23-Jul-14 04:32PM  Why Do We Watch the Dow Jones So Closely When its Makeup Makes No Sense? at Motley Fool
02:18PM  More Questions Raised About Boehringer Ingelheim's Pradaxa at Forbes
02:06PM  Why Puma Biotechnology Inc Stock More Than Tripled Today at Motley Fool
11:19AM  Today's Market: Biotech Names Rallying Today at Seeking Alpha
10:39AM  [video] Faber Report: Puma Biotech surges at CNBC
10:34AM  Puma Biotech up more than 270% in one day Hot Stock Minute
08:37AM  Prempro Plaintiffs Lawyers Settle $62 Million Fee Fight at Bloomberg
22-Jul-14 02:38PM  [video] Don't Expect Tax Inversion Fever to Break Anytime Soon at TheStreet
11:41AM  Top U.S. lawmaker wants corporate tax loophole 'plugged now' Reuters
10:52AM  No Need To Envy Tax-Inversion Takeovers: Better Tax Deal Awaits at Forbes
05:52AM  Bad Times Continue To Hit Merck's Animal Health Segment at Seeking Alpha
21-Jul-14 07:05PM  U.S. Senate panel to debate wave of corporate tax-avoidance deals Reuters
04:56PM  [video] Obstacle races attract sponsors at CNBC
02:36PM  Pfizer's Stock Falls Ill as the Dow Tumbles at Motley Fool
01:41PM  [video] Spartan Race eyes Olympic placement at CNBC
01:03PM  ABBV, MRK And PFE, Pushing Health Care Sector Downward at TheStreet
11:34AM  Tax inversions allow firms to avoid state taxes at USA TODAY
09:59AM  3 Stocks Reiterated As A Buy: PFE, ORCL, PEP at TheStreet
18-Jul-14 03:45PM  Bristol-Myers/Pfizer Commence Phase IV Study on Eliquis Zacks
02:36PM  Two rules of thumb for dumping your financial adviser at MarketWatch
12:52PM  AbbVie Is Biggest to Quit U.S. Address in $55 Billion Shire Deal Bloomberg
12:01PM  AbbVie Is Biggest to Quit U.S. Address in $55 Billion Shire Deal Bloomberg
10:37AM  Shire Agrees to AbbVie $55B Takeover Offer at TheStreet
08:33AM  Drugmakers announce tax-cutting merger at CNNMoney.com
08:04AM  Pep Boys, Buenaventura, Pfizer, Mylan and AstraZeneca highlighted as Zacks Bull and Bear of the Day Zacks
06:31AM  AbbVie Seals $54.8 Billion Shire Deal in Booming Tax Migration From U.S. Bloomberg
05:55AM  Is Roche Eyeing Up A Bid For AstraZeneca plc? at Motley Fool
05:13AM  AbbVie to Buy Shire for $54.8 Billion as Drug Deals Surge Bloomberg
03:09AM  The Hippie Hobby Lobby: Eden Foods Says No to Birth Control at BusinessWeek
17-Jul-14 04:53PM  AbbVie, Shire set to announce merger as early as Friday: report at MarketWatch
02:40PM  Pfizer Eyes InnoPharma, Acquisition to Boost Injectables Biz Zacks
12:25PM  Democrats Rally Against Tax Deals With Eye on Elections at Bloomberg
11:12AM  Alzheimer's Rates Falling, But Pharma's Search For A Cure Yields No Results Benzinga
11:12AM  Alzheimer's Rates Falling, But Pharma's Search For a Cure Yields No Results Benzinga
10:17AM  Pfizer Bolsters Injectables by Buying InnoPharma at TheStreet
08:08AM  [video] Mega-Mergers Deals, The Search for Scale at Bloomberg
08:06AM  Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion Business Wire
02:44AM  Xalkori: Pfizer's Lung Cancer Drug Might Get A Future Boost In Sales at Seeking Alpha
16-Jul-14 06:16PM  Kirkland Snags M&A Tax Partner From Skadden at The Wall Street Journal
05:44PM  Why Pfizer Could Beat This Sector Peer at Seeking Alpha
01:24PM  Should Roche's Failed Trial Give Hope To Alzheimer's Patients? at Forbes
12:58PM  Why Pfizer (PFE) Stock Is Up Today at TheStreet
11:12AM  One Reason Why AstraZeneca plc Is A Risky Bet at Motley Fool
10:28AM  Obama administration urges Congress to act on tax-driven mergers Reuters
10:17AM  [$$] Pfizer Agrees to Buy InnoPharma at The Wall Street Journal
10:00AM  #FOGO? New Survey Reveals 87% of Americans have a Fear of Getting Old (FOGO) Results Show Top Fear is Decline in Physical Ability1 Business Wire
09:26AM  Pfizer to Acquire InnoPharma, Inc. Business Wire
09:15AM  Will Congress Block Tax Inversions? at Fox Business
08:37AM  Pfizer: Struggling Through A Tough Time at Seeking Alpha
08:14AM  [$$] Pfizer Hemophilia B Treatment Regimen Meets Endpoint at The Wall Street Journal
08:11AM  Pfizer says clotting drug's once-weekly dose reduces bleeding rate Reuters
07:04AM  Pfizer says primary endpoint met in Phase 3 study of BeneFIX theflyonthewall.com
07:00AM  Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®) Once-Weekly Prophylaxis For Hemophilia B Business Wire
15-Jul-14 08:49PM  With Tips From Pfizer, AbbVie Lands the Biggest Pharma Deal of the Year: StockTwits at TheStreet
07:56PM  Pfizer to Inject Youth Into the Aging Process at New York Times
07:56PM  Pfizer to Inject Youth Into the Aging Process at New York Times
12:34PM  Heres why Congress lets U.S. companies dodge taxes Yahoo Finance
11:09AM  Italian Ajani Emerges as Drug Billionaire in Switzerland Bloomberg
10:56AM  Italian Ajani Emerges as Drug Billionaire in Switzerland Bloomberg
12:00AM  Italian Ajani Emerges as Drug Billionaire in Switzerland Bloomberg
12:00AM  Italian Ajani Emerges as Drug Billionaire in Switzerland at Bloomberg
14-Jul-14 05:45PM  Stocks close higher, Dow leaps back above 17,000 at USA TODAY
05:26PM  Drugmakers Shire, AbbVie near $53B merger at USA TODAY
05:09PM  How the Dow Jones industrial average did Monday AP
04:08PM  Stocks close higher, Dow leaps back above 17,000 at USA TODAY
03:50PM  Drugmakers Shire, AbbVie near $53B merger at USA TODAY
03:09PM  Stocks spring higher, Dow over 17,000 again at USA TODAY
12:57PM  Drugmakers Shire, AbbVie close in on $53B merger at USA TODAY
12:12PM  [video] Shire and AbbVie in $54B Deal Talks Following Sweetened Bid at TheStreet
11:18AM  Stocks spring higher, Dow over 17,000 again at USA TODAY
10:25AM  Mylan To Acquire Non-U.S. Business From Abbott For $5.3 Billion at Forbes
09:53AM  Drugmakers Shire, AbbVie close in on $53B merger at USA TODAY
07:02AM  Johnson & Johnson Earnings: Can Pharma Keep Stoking Growth? at Motley Fool
06:45AM  A Call for Stricter Takeover Rules in Britain at New York Times
05:37AM  Premarkets: 5 things to know before the open at CNNMoney.com
11-Jul-14 02:44PM  Abbott, Nestle, Prepare to Profit from Chinas Upcoming Baby Boom at TheStreet
12:29PM  3 Stocks Reiterated As A Buy: PFE, QCOM, YHOO at TheStreet
08:16AM  If Big Pharma Ignores Antibacterial R&D, Where Will We Get The Drugs To Treat Superbugs? at Forbes
06:52AM  [video] Big pharma's big battle with Alzheimer's at CNBC
06:29AM  India's Sun Pharma recalls over 40,000 bottles of antidepressant Reuters
10-Jul-14 02:05PM  Is Pfizer A Good Dividend Pick? at Seeking Alpha
08:26AM  Pharma's Poor Reputation Doesn't Help In The Fight Against Superbugs at Forbes
06:00AM  'Mad Money' Lightning Round: AT&T Is a Buy at TheStreet
09-Jul-14 04:30PM  [video] The Top Ten Stocks for July 9 at Bloomberg
02:29PM  Lung Cancer Genomic Mapping Yields New Targets in Study at Bloomberg
09:43AM  What RXi Pharmaceuticals Move to the Russell Microcap Index Means Accesswire
05:42AM  Decoding U.K. Rules Shouldn't Mean Silence at The Wall Street Journal
08-Jul-14 08:27PM  Pfizer wins dismissal of U.S. investor class action ahead of trial Reuters
07:19PM  PRESS DIGEST- British Business - July 9 Reuters
03:11PM  Punishing Walgreen For Leaving The U.S. Might Be More Complicated Than Robert Reich Thinks at Forbes
02:37PM  Tax Inversions: A Look at Five Cross-Border Deals with Big Price Tags at The Wall Street Journal
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products. The company's Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company's Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company also offers Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It serves wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. It has strategic alliance with CliniWorks (Israel) Ltd. to develop population health management platform with advanced analytics and patient care capabilities. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OLSON LAURIE JExecutive Vice PresidentJun 12Option Exercise26.2036,275950,40593,010Jun 13 12:29 PM
OLSON LAURIE JExecutive Vice PresidentJun 12Sale29.5336,2751,071,27856,735Jun 13 12:29 PM
YOUNG JOHN DGroup PresidentMar 17Sale31.389,000282,42099,647Mar 18 09:33 AM
PFIZER INC10% OwnerMar 12Buy11.00272,7272,999,9971,235,330Mar 14 03:27 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale32.5967,5852,202,872173,637Mar 05 05:36 PM
Dolsten MikaelPresident R&DMar 04Sale32.5835,7891,165,929344,571Mar 05 05:36 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 04Sale32.555,082165,419171,756Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Option Exercise26.2075,5001,978,100274,699Mar 05 05:37 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerMar 03Sale32.0297,8613,133,674176,838Mar 05 05:37 PM
READ IAN CChairman & CEOFeb 26Option Exercise12.70324,9324,126,6361,410,536Feb 28 04:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise12.70130,8751,662,113312,499Feb 28 04:52 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise12.7057,586731,342116,884Feb 28 04:52 PM
BOURLA ALBERTGroup PresidentFeb 26Option Exercise12.7021,482272,82192,447Feb 28 04:52 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise12.7056,411716,420228,878Feb 28 04:52 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise12.70324,9324,126,636615,673Feb 28 04:52 PM
HILL CHARLES HExecutive Vice PresidentFeb 26Option Exercise12.7034,731441,084104,046Feb 28 04:52 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise12.7034,568439,014120,562Feb 28 04:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12740,480Feb 28 04:52 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 26Option Exercise12.7029,695377,12783,716Feb 28 04:52 PM
OLSON LAURIE JExecutive Vice PresidentFeb 26Option Exercise12.7031,772403,50468,167Feb 28 04:52 PM
PFIZER INC10% OwnerFeb 04Buy8.00227,2611,818,0881,794,803Feb 06 03:53 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.82131,8104,062,225356,451Jan 14 07:13 PM
DAMELIO FRANK AExecutive Vice PresidentJan 13Sale30.8628,190869,817328,261Jan 14 07:13 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Option Exercise26.2092,0002,410,400152,447Nov 18 03:31 PM
MADDALUNA ANTHONY JExecutive Vice PresidentNov 14Sale32.1092,0002,953,06360,447Nov 18 03:31 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerNov 01Sale31.2010,000311,985174,841Nov 04 03:59 PM
READ IAN CChairman & CEOOct 28Option Exercise26.20338,0008,855,6001,412,267Oct 29 05:44 PM
READ IAN CChairman & CEOOct 28Sale30.57338,00010,331,3151,074,267Oct 29 05:44 PM
LANKLER DOUGLAS MExecutive Vice PresidentSep 16Option Exercise26.0660,9001,587,198150,617Sep 18 04:27 PM
LANKLER DOUGLAS MExecutive Vice PresidentSep 16Sale28.7060,9001,748,02589,717Sep 18 04:27 PM
Lewis-Hall Freda CExecutive Vice PresidentSep 16Sale28.7038,4611,103,831118,383Sep 18 04:20 PM
CORNWELL W DONDirectorAug 12Buy29.0975822,0502,217Aug 13 03:58 PM
CORNWELL W DONDirectorAug 12Sale29.0975822,0501,459Aug 13 03:58 PM
HILL CHARLES HExecutive Vice PresidentJul 31Option Exercise26.0496,5002,512,460171,362Aug 01 05:39 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerJul 31Sale29.6314,688435,180183,703Aug 01 05:39 PM
HILL CHARLES HExecutive Vice PresidentJul 31Sale29.6496,5002,860,43474,862Aug 01 05:39 PM